These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 3576071

  • 1. Sulfation of N-hydroxy-2-acetylaminofluorene in normal and nodular liver from male Wistar rats.
    Blanck A, Wicksell L, Eriksson LC.
    Toxicol Pathol; 1987; 15(1):103-5. PubMed ID: 3576071
    [Abstract] [Full Text] [Related]

  • 2. Loss of sexual differentiation of metabolism of steroids and xenobiotics in nodular hepatic tissue from male and female Wistar rats treated according to the resistant hepatocyte model.
    Blanck A, Hällström IP, Eriksson LC.
    Carcinogenesis; 1990 Jul; 11(7):1067-73. PubMed ID: 2372866
    [Abstract] [Full Text] [Related]

  • 3. The role of N-sulfation in the N-hydroxy-2-acetylaminofluorene-mediated outgrowth of diethylnitrosamine-initiated hepatocytes to gamma-glutamyltranspeptidase-positive foci in male rat liver.
    Kroese ED, van de Poll ML, Mulder GJ, Meerman JH.
    Carcinogenesis; 1988 Nov; 9(11):1953-8. PubMed ID: 2902938
    [Abstract] [Full Text] [Related]

  • 4. Autoradiographic studies on in vivo covalent binding of N-hydroxy-2-acetylaminofluorene in rat liver containing gamma-glutamyltranspeptidase-positive foci. The effect of the sulfation-inhibitor pentachlorophenol.
    Kroese ED, Tijdens RB, Mulder GJ, Meerman JH.
    Carcinogenesis; 1987 Apr; 8(4):571-5. PubMed ID: 2881632
    [Abstract] [Full Text] [Related]

  • 5. Role of sulfation in the formation of DNA adducts from N-hydroxy-2-acetylaminofluorene in rat liver in vivo. Inhibition of N-acetylated aminofluorene adduct formation by pentachlorophenol.
    Meerman JH, Beland FA, Mulder GJ.
    Carcinogenesis; 1981 Apr; 2(5):413-6. PubMed ID: 7273322
    [Abstract] [Full Text] [Related]

  • 6. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells.
    Glowinski IB, Sanderson ND, Hayashi S, Thorgeirsson SS.
    Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396
    [Abstract] [Full Text] [Related]

  • 7. Changes in rat liver N-hydroxy-2-acetylaminofluorene aryl sulfotransferase activity at early and late stages of hepatocarcinogenesis resulting from dietary administration of 2-acetylaminofluorene.
    Ringer DP, Norton TR, Cox B, Howell BA.
    Cancer Lett; 1988 Jun 30; 40(3):247-55. PubMed ID: 3164251
    [Abstract] [Full Text] [Related]

  • 8. N-sulfoöxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J x C3H/HeJ F1 (B6C3F1) mice.
    Lai CC, Miller JA, Miller EC, Liem A.
    Carcinogenesis; 1985 Jul 30; 6(7):1037-45. PubMed ID: 3860305
    [Abstract] [Full Text] [Related]

  • 9. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide.
    Hinson JA, Andrews LS, Gillette JR.
    Natl Cancer Inst Monogr; 1981 Dec 30; (58):113-6. PubMed ID: 6176868
    [No Abstract] [Full Text] [Related]

  • 10. Sex differences in sulfation and glucuronidation of phenol, 4-nitrophenol and N-hydroxy-2-acetylaminofluorene in the rat in vivo.
    Meerman JH, Nijland C, Mulder GJ.
    Biochem Pharmacol; 1987 Aug 15; 36(16):2605-8. PubMed ID: 3606659
    [Abstract] [Full Text] [Related]

  • 11. Correlation between clastogenicity and promotion activity in liver carcinogenesis by N-hydroxy-2-acetylaminofluorene, N-hydroxy-4'-fluoro-4-acetylaminobiphenyl and N-hydroxy-4-acetylaminobiphenyl.
    van de Poll ML, van der Hulst DA, Tates AD, Meerman JH.
    Carcinogenesis; 1990 Feb 15; 11(2):333-9. PubMed ID: 2302760
    [Abstract] [Full Text] [Related]

  • 12. Progressive DNA damage in hepatic nodules during 2-acetylaminofluorene carcinogenesis.
    Stout DL, Becker FF.
    Cancer Res; 1980 Apr 15; 40(4):1269-73. PubMed ID: 7357556
    [Abstract] [Full Text] [Related]

  • 13. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C, Batardy-Grégoire M, Roberfroid M.
    Cancer Res; 1982 Nov 15; 42(11):4712-8. PubMed ID: 7127306
    [Abstract] [Full Text] [Related]

  • 14. Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene.
    Beranek DT, White GL, Heflich RH, Beland FA.
    Proc Natl Acad Sci U S A; 1982 Sep 15; 79(17):5175-8. PubMed ID: 6752940
    [Abstract] [Full Text] [Related]

  • 15. The variations of S-adenosyl-L-methionine content modulate hepatocyte growth during phenobarbital promotion of diethylnitrosamine-induced rat liver carcinogenesis.
    Feo F, Garcea R, Pascale R, Pirisi L, Daino L, Donaera A.
    Toxicol Pathol; 1987 Sep 15; 15(1):109-14. PubMed ID: 2883718
    [Abstract] [Full Text] [Related]

  • 16. Persistence and growth of rat liver neoplastic nodules following cessation of carcinogen exposure.
    Hirota N, Williams GM.
    J Natl Cancer Inst; 1979 Nov 15; 63(5):1257-65. PubMed ID: 291752
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of sulfate conjugation of N-hydroxy-2-acetylaminofluorene in isolated perfused rat liver and in the rat in vivo by pentachlorophenol and low sulfate.
    Meerman JH, van Doorn AB, Mulder GJ.
    Cancer Res; 1980 Oct 15; 40(10):3772-9. PubMed ID: 6159969
    [No Abstract] [Full Text] [Related]

  • 18. Sulfotransferase and deacetylase in normal and tumor-bearing liver of CD rats: autoradiographical studies with N-hydroxy-2-acetylaminofluorene and N-hydroxy-4-acetylaminobiphenyl in vitro and in vivo.
    Shirai T, King CM.
    Carcinogenesis; 1982 Oct 15; 3(12):1385-91. PubMed ID: 6960974
    [Abstract] [Full Text] [Related]

  • 19. Development of resistance during the early stages of experimental liver carcinogenesis.
    Yusuf A, Rao PM, Rajalakshmi S, Sarma DS.
    Carcinogenesis; 1999 Aug 15; 20(8):1641-4. PubMed ID: 10426821
    [Abstract] [Full Text] [Related]

  • 20. Effects of neonatal and adult castration on the in vitro metabolism of steroids and xenobiotics in rat liver.
    Blanck A, Aström A, Hansson T.
    Cancer Res; 1986 Oct 15; 46(10):5072-6. PubMed ID: 3756865
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.